Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Correction

Correction: Effect of chlorhexidine Mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial

Authors: Na Young Kim, Jae Hyeon Park, Jimyung Park, Nakwon Kwak, Sun Mi Choi, Young Sik Park, Chang-Hoon Lee, Jaeyoung Cho

Published in: BMC Cancer | Issue 1/2023

Login to get access

Excerpt

Correction: BMC Cancer 22, 1334 (2022)
Metadata
Title
Correction: Effect of chlorhexidine Mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial
Authors
Na Young Kim
Jae Hyeon Park
Jimyung Park
Nakwon Kwak
Sun Mi Choi
Young Sik Park
Chang-Hoon Lee
Jaeyoung Cho
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10505-1

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine